A5076914790- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Healthcare Systems and Reforms
- Sinusitis and nasal conditions
- Allergic Rhinitis and Sensitization
- Sexual Differentiation and Disorders
- Antifungal resistance and susceptibility
- Dental Research and COVID-19
- Lung Cancer Treatments and Mutations
- Pomegranate: compositions and health benefits
- Head and Neck Surgical Oncology
- Sexual function and dysfunction studies
- Peripheral Artery Disease Management
- Economic and Financial Impacts of Cancer
- Advanced Breast Cancer Therapies
- COVID-19 Clinical Research Studies
- Chemistry and Chemical Engineering
- Spinal Cord Injury Research
- Patient Satisfaction in Healthcare
- Pharmaceutical studies and practices
- Pulmonary Hypertension Research and Treatments
- Urinary Tract Infections Management
- Urinary Bladder and Prostate Research
- Radiomics and Machine Learning in Medical Imaging
- Cardiovascular Issues in Pregnancy
Shahid Beheshti University of Medical Sciences
2018-2023
Pontificia Universidad Católica de Chile
2023
Tehran University of Medical Sciences
2012-2017
Sarem Cell Research Center
2016
Khatam University
2016
Evaluation of pharmaceutical systems performance is an essential prerequisite for promoting evidence-based policy-making and improvement in health system performance. This study attempts to evaluate the Iran based on world organization (WHO)'s indicators, including access, quality, rational use medicines. In this cross-sectional descriptive study, inspired by instructions proposed WHO, public private service-providers were evaluated three dimensions 16 indicators. Accordingly, eleven...
Obtaining a comprehensive understanding of green management in the pharmaceutical industry is important developing countries to inform policymakers, minimize industry's environmental impact, protect public health, reduce costs, and improve reputation companies.Tailored solutions are needed address challenges countries, as their nature incentives differ from those developed countries.This study investigates current state Iran, providing insights into practices that can effective policies...
Background: Overactive bladder (OAB) is a symptomatic condition characterized by urinary urgency with or without incontinence, usually associated frequent daytime urination, enuresis, and nocturia. Objectives: This economic evaluation was aimed at assessing the cost-effectiveness of mirabegron versus solifenacin in treatment OAB patients from payer’s perspective Iran. Methods: A Markov model 5-year time horizon used. The consisted five health states, an average age 60 years entered cycle...
Background: In addition to clinical and technical considerations, patients’ preferences are essential for evaluating interventions such as precision medicine (PM). Objectives: This study aimed identify prioritize attributes of oncology that important patients develop validate a standard stated preference instrument. Methods: The key their related levels were extracted from the systematic literature review presented on validated 5-point Likert scale questionnaire experts (n = 35). two rounds...